- Filed
- Apr 30, 2026 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 9.05M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 9.13M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $540K |
| Capex | Q1 2026 · Mar 31, 2025 | $1.04M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $338K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$34.91M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $27.99M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $12.74M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $82.06M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $86.73M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $164.3M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $113.46M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $600.19M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $557.59M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | $0.06 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | $0.30 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | $0.06 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | $0.30 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $35.91M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $33M |
| Net Income | Q1 2026 · Mar 31, 2026 | $565K |
| Net Income | Q1 2026 · Mar 31, 2025 | $2.68M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $40.45M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $53.53M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $165.99M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $171.19M |
| Revenue | Q1 2026 · Mar 31, 2026 | $206.44M |
| Revenue | Q1 2026 · Mar 31, 2025 | $224.72M |